Loading events...
This event listing is based on historical patterns and may not be officially confirmed. Dates, venue, and details are subject to change. Please verify with the event organizer or official website before making travel arrangements.
Verify on official websiteInnate Pharma to highlight IPH4502, its lead Nectin-4 Antibody Drug Conjugate (ADC) program at clinical stage. The event will be held in New York in a hybrid format to share the latest scientific and clinical advancements related to Nectin-4 and its potential in cancer treatment.
Innate Pharma to highlight IPH4502, its lead Nectin-4 Antibody Drug Conjugate (ADC) program at clinical stage. The event will be held in New York in a hybrid format to share the latest scientific and clinical advancements related to Nectin-4 and its potential in cancer treatment.
Wednesday, February 5, 2025
New York, USA
Receive curated event recommendations based on your interests.
See how WebMobi helps you manage registration, check-in, and analytics.
Request a DemoOr start free trial →Innate Pharma announces Nectin-4 antibody drug conjugate investor and analyst event in New York takes place on Wednesday, February 5, 2025.
Innate Pharma announces Nectin-4 antibody drug conjugate investor and analyst event in New York is held in New York, USA.
Pricing information is available on the event website.
Innate Pharma announces Nectin-4 antibody drug conjugate investor and analyst event in New York is designed for healthcare professionals looking to network, learn, and discover new opportunities.
Get curated B2B events, AI-powered insights, and industry trends delivered to your inbox